19 June 2013
27 April 1992
US biotechnology company Bio-Technology General Corp has received approval to market Eskatrope, its recombinant version of human growth hormone which...
27 April 1992
Upjohn has received marketing approval from the US Food and Drug Administration for an improved formulation of its leading antidiabetic...
27 April 1992
Russell McLauchlan has resigned as president of Immuno-medics. According to the company, a successor is expected to be announced by...
27 April 1992
Belmac Europe has launched three oral powder formulations of erythromycin, under the trade name Biolid, onto the French market. The...
27 April 1992
US pharmaceutical company Chiron's Dutch subsidiary, EuroCetus BV, has received approval from the Austrian Board of Health to market Proleukin...
27 April 1992
The accelerated approval proposal which the US Food and Drug Administration published this month changes the set of principles which...
27 April 1992
Japan's Tanabe Seiyaku Company and Omron Corp report that they have jointly developed a tympanic thermometer, the Quick Thermo MC-500,...
27 April 1992
Moves to reduce exemptions from the Antimonopoly Law, by halving the number of products eligible for a system that allows...
27 April 1992
The debate as to how to control ever-rising German health care spending has intensified with controversial new proposals from the...
27 April 1992
Instituto Farmacologico Serono, which is listed on the Rome bourse, ended 1991 with 6.7 million lire ($5.4 million) profit, down...